FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons to update the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

SUPPL AP for BARACLUDE (ENTECAVIR)